A new study involving shooting X-rays at crystals has uncovered the precise three-dimensional structure of an enzyme associated with Alzheimer's disease, allowing researchers to now use powerful computers to discover drug-like molecules to treat the disease.
A new world class Heart Exercise and Research Trials (HEART) Laboratory has been established thanks to a collaborative partnership between SVI and the Victor Change Cardiac Research Institute.
A heartfelt thank you to Susan Alberti AC and the late Colin North OAM for their vision and support, which make this program possible. Together, we are shaping the future of medical research - ensuring that tomorrow’s leaders are prepared to tackle the pressing health issues of our time.
What can medical research fundraisers learn from retail, property, and finance sales experts? A lot! Board members and staff participated in an insightful and engaging thought leadership session this week. Among the many themes discussed was workplace giving and the need for new equipment.
It is with great sadness that we announce the death of Professor Helen Thomas, an outstanding medical researcher whose work in type 1 diabetes made a significant impact.
Research shows the benefits in integrating AI to read mammograms
SVI will receive $100,000 to develop new treatments for non-alcoholic fatty liver disease harnessing mRNA editing technology. This condition impacts over 5 million Australians and is a leading risk factor for cardiovascular disease and type 2 diabetes.
SVI is grateful to Ruth for leaving a major gift to help medical research. A gift in your Will is an immensely powerful way to make a difference, whether you’ve been personally affected by the diseases we study at SVI, or simply want to invest in the future health of our community.
The Big St Vs were courageous in the annual MRI Footy Tournament in clashes against WEHI and Peter Mac at Royal Park. Fuelled by lolly snakes and sausages, our ferocious team took to the field to prove their mettle.
It is more important than ever to increase funding for medical research institutes to be able to continue their life-changing projects
It is with sadness that we acknowledge the death of Dr Frank Morgan (1940-2024), SVI’s second Director.
Dr McLeman is set to receive $15,000 from the Col Reynolds Fellowship Program established by The Kids' Cancer Project. Named for founder Col Reynolds OAM, the aim of the Fellowships is to future proof childhood cancer research by encouraging new researchers and retaining talented scientists in the field of childhood cancer research.
Professor Jack Martin’s research began a discovery cascade that led to the identification of a revolutionary new protein and the development of a novel and effective drug therapy that is now used worldwide to treat osteoporosis, cancer and other diseases
Dr Liz Paratz receives four prestigious awards for her work in sudden cardiac arrest
A wrap up of our latest achievements. Congratulations to Davis, Jarmon, Louise, Vita and Li.
Head of SVI’s Human Genomics and Evolution Lab, Associate Professor Irene Gallego Romero has been studying the ways in which natural selection and evolution have shaped humanity and to understand how our species' past defines our present.
Congratulations to Dr. Kim Loh, A/Prof. Jonathan Oakhill, Dr. Christopher Meoli on their selection into the Inaugural MedChem Australia Projects initiative. Their research project focus is on 'Developing a new protein kinase inhibitor for metabolic disease'.
Until recently, gene editing technologies were science fiction but now, Andrew’s team is developing cutting edge gene edition technologies that hope to prevent children and young adults from dying of inherited bone marrow failure syndromes.
SVI proudly welcomes Dr Elizabeth Paratz, who has joined SVI’s Heart, Exercise and Research Trials (HEART) Lab as a Team Leader. Dr Paratz will lead a team of SVI researchers, working closely with Professor La Gerche and scientists at VCCRI, who are also undertaking research into sudden cardiac arrest.
A four-year grant of $2.9M, announced in June from the Medical Research Future Fund’s Genomics Health Futures Grant will support a multi-centre and multidisciplinary team led by SVI’s Associate Professor Elaine Sanij to identify and validate blood biomarkers to provide early detection of multiple myeloma and to monitor disease progression and response to treatment.